Hamed Najafabadi
@hsnajafabadi
Core member @McGillGenome, Associate Professor @Human_Genetics @mcgillu, studying gene regulation in human cells.
Joining forces with Babak Alipanahi, @DavisCompGen, @AidenSababi & @MKarimzade to bring you Exai-1; a multi-modal cell-free RNA foundation model for blood surveillance and liquid biopsy. Kudos to the broader @exaibio team for getting this across the line. biorxiv.org/content/10.110…
So we beat on. Gene/cell therapies often use proteins that could be recognized/rejected as non-self by our immune system. We combine algorithms to build proteins that are therapeutically relevant and can masquerade as our own parts doi.org/10.1101/2025.0…
How do early lung tumors evolve? Our latest preprint, led by Junbum Kim, maps early-stage cancer at single-cell resolution, revealing two key pathways: 🦠Driven by immune activity 🛠️ Driven by fibrosis These insights could refine detection & treatment biorxiv.org/content/10.110…
I don’t post here much anymore, but this one is an important announcement for us: 🚨We are Recruiting! So come join us! 🚨#RNA #CancerResearch
Happy to share our new paper in Nature Biomedical Engineering! Special congratulations to the first author, Dr. Reza Rezaei, and our amazing collaborators. @Rezaeir75 @Tai_ImmunoLab @TommyAlain3 rdcu.be/d1MzQ nature.com/articles/s4155…
(1/13) Excited to present the results of the large-scale benchmarking of DNA motif discovery tools using the Codebook data compendium on poorly studied human transcription factors and the Codebook Motif Explorer dx.doi.org/10.1101/2024.1… | mex.autosome.org⬇️